The research discussed in this episode focuses on how low doses of the drug ketamine produce fast and long-term antidepressant effects and identifies the gene (MeCP2) and processes in the brain that are involved. 

VKC Researcher: Lisa Monteggia, Ph.D., Barlow Family Director of the Vanderbilt Brain Institute; Professor of Pharmacology

Interviewer: Jeffrey L. Neul, M.D., Ph.D., Annette Schaffer Eskind Chair and Director, Vanderbilt Kennedy Center; Professor of Pediatrics, Division of Neurology, Pharmacology, and Special Education